May 28, 20240000920148false00009201482024-05-282024-05-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

May 28, 2024
(Date of earliest event reported)
LABCORP HOLDINGS INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware1-1135313-3757370
(State or other jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

358 South Main Street 
Burlington,North Carolina27215
(Address of principal executive offices)(Zip Code)
(Registrant’s telephone number including area code) 336-229-1127
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Exchange Act.
Title of Each Class            Trading Symbol            Name of exchange on which registered
Common Stock , $0.10 par value        LH                New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).             
                                        Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 7.01Regulation FD Disclosure
On May 28, 20-24, Laboratory Corporation of America Holdings announced a global leader of innovative and comprehensive laboratory services, announced that members of the executive management team will participate in a presentation at the 44th Annual William Blair Growth Stock Conference on Tuesday, June 4 at 2:00 p.m. (CT).

Item 9.01
Financial Statements and Exhibits.

ExhibitExhibit Name
Exhibit 99.1
Exhibit 104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LABORATORY CORPORATION OF AMERICA HOLDINGS
Registrant

 By:/s/ SANDRA VAN DER VAART
  Sandra van der Vaart
  Executive Vice President, Chief Legal Officer and Corporate Secretary

May 28, 2024


lc2020logov2.gif



FOR IMMEDIATE RELEASE

Labcorp Contacts:
Investors: Christin O'Donnell — 336-436-5076
Investor@Labcorp.com

Media: Kimbrel Arculeo — 336-436-8263
Media@Labcorp.com


Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference

BURLINGTON, N.C., May 28, 2024 – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a presentation at the 44th Annual William Blair Growth Stock Conference on Tuesday, June 4 at 2:00 p.m. (CT).

About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com.

# # #


v3.24.1.1.u2
Cover page Cover page
May 28, 2024
Cover page. [Abstract]  
Written Communications false
Entity Address, Address Line One 358 South Main Street
Entity Tax Identification Number 13-3757370
Entity Central Index Key 0000920148
Document Period End Date May 28, 2024
Entity Registrant Name LABCORP HOLDINGS INC.
City Area Code 336
Local Phone Number 229-1127
Title of 12(b) Security Common Stock , $0.10 par value
Trading Symbol LH
Security Exchange Name NYSE
Entity Emerging Growth Company false
Amendment Flag false
Entity Incorporation, State or Country Code DE
Entity File Number 1-11353
Entity Address, City or Town Burlington,
Entity Address, State or Province NC
Entity Address, Postal Zip Code 27215
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Document Type 8-K
Labcorp (NYSE:LH)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Labcorp Charts.
Labcorp (NYSE:LH)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Labcorp Charts.